Literature DB >> 21989558

Accumulation of visceral fat in maintenance hemodialysis patients.

Takatomi Yurugi1, Satoshi Morimoto, Takayuki Okamoto, Yoshifumi Amari, Yuko Kasuno, Masayoshi Fukui, Fumitaka Nakajima, Mitsushige Nishikawa, Toshiji Iwasaka.   

Abstract

BACKGROUND: In hemodialysis (HD) patients, obesity has been recognized as a serious risk factor for mortality and morbidity for cardiovascular diseases. In addition, abnormalities of lipid profiles exist in these patients.
METHODS: In patients undergoing maintenance HD, incidences of abnormality of lipid profiles and visceral obesity determined by computed tomography scans were compared. In addition, the relationship between visceral fat area (VFA) and brachial-ankle pulse wave velocity (baPWV), an index of arterial stiffness, or carotid intima-media thickness (IMT), an index of atherosis, was examined.
RESULTS: The incidence of high VFA (27.0%) was significantly greater than that of high body mass index (BMI) (9.7%), high low-density-lipoprotein cholesterol (LDL-C) (4.8%), and high triglyceride (12.7%). In patients with diabetes mellitus (DM), waist circumference and VFA showed a significant positive relationship with baPWV. baPWV was significantly higher in patients with high VFA and DM than in patients with low VFA without DM, those with high VFA without DM, and those with low VFA and DM. Carotid IMT was significantly greater in patients with high VFA and DM than in those with low VFA without DM and those with low VFA and DM.
CONCLUSIONS: The incidence of high VFA was much greater than that of high BMI, high LDL-C, or high triglyceride. Visceral fat accumulation may be related to both arterial stiffness and atherosis in diabetic patients on maintenance HD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989558     DOI: 10.1007/s10157-011-0544-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  50 in total

1.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

2.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Excerpts from the United States Renal Data System 1998 Annual Data Report.

Authors: 
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 5.  Role of chronic kidney disease in cardiovascular disease: are we different from others?

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2011-04-05       Impact factor: 2.801

6.  Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients.

Authors:  M Odamaki; R Furuya; S Ohkawa; T Yoneyama; M Nishikino; A Hishida; H Kumagai
Journal:  Nephrol Dial Transplant       Date:  1999-10       Impact factor: 5.992

7.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

8.  International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

Authors:  Beverley Balkau; John E Deanfield; Jean-Pierre Després; Jean-Pierre Bassand; Keith A A Fox; Sidney C Smith; Philip Barter; Chee-Eng Tan; Luc Van Gaal; Hans-Ulrich Wittchen; Christine Massien; Steven M Haffner
Journal:  Circulation       Date:  2007-10-23       Impact factor: 29.690

9.  Risk factors of normal ankle-brachial index and low toe-brachial index in hemodialysis patients.

Authors:  Satoshi Morimoto; Fumitaka Nakajima; Takatomi Yurugi; Tatsuyori Morita; Fusakazu Jo; Mitsushige Nishikawa; Toshiji Iwasaka; Kei Maki
Journal:  Ther Apher Dial       Date:  2009-04       Impact factor: 1.762

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  4 in total

Review 1.  Arterial Stiffening and Clinical Outcomes in Dialysis Patients.

Authors:  Akihiko Kato
Journal:  Pulse (Basel)       Date:  2015-05-14

2.  Relationship between arterial stiffening and skeletal muscle atrophy in hemodialysis patients: a gender comparative study.

Authors:  Akihiko Kato; Takako Takita; Hiromichi Kumagai
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-06-05       Impact factor: 12.910

3.  Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients.

Authors:  Yoshifumi Amari; Satoshi Morimoto; Fumitaka Nakajima; Takashi Ando; Atsuhiro Ichihara
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

4.  Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes.

Authors:  Arnaud Delautre; François Chantrel; Yves Dimitrov; Alexandre Klein; Olivier Imhoff; Clotilde Muller; Nicole Schauder; Thierry Hannedouche; Thierry Krummel
Journal:  BMC Nephrol       Date:  2020-08-13       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.